Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Exscientia plc
Exscientia Achieves Milestones for Two Programmes in Sanofi Collaboration
October 16, 2024
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ENA 2024
October 09, 2024
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
August 28, 2024
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia Business Update for Second Quarter and First Half 2024
August 15, 2024
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia Acquires Full Rights to Potential Best-in-Class CDK7 Inhibitor Ahead of Phase 1 Dose Escalation Data Readout
July 18, 2024
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia Launches AWS AI-powered Platform to Advance Drug Discovery
July 10, 2024
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia Appoints New Leaders to Strengthen the Impact of Integrated Technologies and Focus Clinical Development Expertise in Oncology
June 06, 2024
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia to Present at Upcoming Investor Conferences in June
May 30, 2024
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia Business Update for First Quarter 2024
May 21, 2024
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia to Report First Quarter 2024 Financial Results on May 21, 2024
May 14, 2024
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia Business and Financial Update for the Full Year 2023
March 21, 2024
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia to Report Full Year 2023 Financial Results on March 21, 2024
March 14, 2024
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia to Present at Upcoming Investor Conferences in March
February 28, 2024
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia Initiates Clinical Study to Further Evaluate Functional Precision Medicine Platform in Cancer Patients
February 07, 2024
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia Announces Expansion of its Current Collaboration with Sanofi to Include Existing Exscientia Programme
December 21, 2023
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia Receives Open Philanthropy Grant to Explore New Therapeutic Approach for Pandemic Influenza
December 05, 2023
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia to Present at the 6th Annual Evercore ISI HealthCONx Conference
November 21, 2023
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia Business Update for Third Quarter 2023
November 09, 2023
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia to Report Third Quarter 2023 Financial Results on November 9, 2023
November 02, 2023
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Parker Moss to Join Exscientia as EVP, Corporate Development
October 17, 2023
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ESMO 2023
October 16, 2023
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia Details Pipeline Prioritisation Strategy
October 03, 2023
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia Announces AI Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany
September 20, 2023
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia to Present at Upcoming Investor Conferences in September
August 31, 2023
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia Business Update for Second Quarter and First Half of 2023
August 10, 2023
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
First Patient Enrolled in Phase 1/2 “ELUCIDATE” Trial Assessing GTAEXS617 in Advanced Solid Tumours
July 10, 2023
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
June 06, 2023
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia Business Update for First Quarter 2023
May 24, 2023
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia Highlights "The Future of AI-enabled Drug Discovery" at SLAS Europe
May 22, 2023
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Exscientia to Report First Quarter 2023 Financial Results on May 24, 2023
May 17, 2023
From
Exscientia plc
Via
Business Wire
Tickers
EXAI
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit